04/19/2024
6:50 AM | Ayala Pharmaceuticals (Filer)
| Form 8-K/A | |
04/16/2024
3:11 PM | Ayala Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
04/15/2024
3:33 PM | Ayala Pharmaceuticals (Filer)
| Form S-8 POS | |
04/15/2024
3:33 PM | Ayala Pharmaceuticals (Filer)
| Form S-8 POS | |
04/15/2024
3:34 PM | Ayala Pharmaceuticals (Filer)
| Form S-8 POS | |
04/15/2024
3:34 PM | Ayala Pharmaceuticals (Filer)
| Form S-8 POS | |
04/15/2024
3:30 PM | Ayala Pharmaceuticals (Filer)
| Form S-8 POS | |
|
04/15/2024
3:31 PM | Ayala Pharmaceuticals (Filer)
| Form S-8 POS | |
04/15/2024
3:31 PM | Ayala Pharmaceuticals (Filer)
| Form S-8 POS | |
04/15/2024
3:32 PM | Ayala Pharmaceuticals (Filer)
| Form S-8 POS | |
04/15/2024
3:32 PM | Ayala Pharmaceuticals (Filer)
| Form S-8 POS | |
04/03/2024
4:01 PM | Ayala Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2024
3:31 PM | Ayala Pharmaceuticals (Filer)
| Form NT 10-K | |
03/29/2024
4:06 PM | Ayala Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
6:13 AM | Ayala Pharmaceuticals (Issuer)
I.B.F. Management Ltd. (Reporting)
Israel Biotech Fund GP Partners II, L.P. (Reporting)
Israel Biotech Fund GP Partners, L.P. (Reporting)
Israel Biotech Fund I, L.P. (Reporting)
Israel Biotech Fund II, L.P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2024
7:16 AM | Ayala Pharmaceuticals (Filer)
| Form DEFM14C | |
02/20/2024
4:22 PM | Ayala Pharmaceuticals (Filer)
| Form PREM14C | |
02/12/2024
1:16 PM | Ayala Pharmaceuticals (Issuer)
I.B.F. Management Ltd. (Reporting)
Israel Biotech Fund GP Partners II, L.P. (Reporting)
Israel Biotech Fund GP Partners, L.P. (Reporting)
Israel Biotech Fund I, L.P. (Reporting)
Israel Biotech Fund II, L.P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
10:58 AM | Ayala Pharmaceuticals (Subject)
Israel Biotech Fund I, L.P. (Filed by)
| Form SC 13D/A | |
02/12/2024
7:27 AM | Ayala Pharmaceuticals (Subject)
Schindel Yair Chaim (Filed by)
| Form SC 13G/A | |
02/09/2024
4:15 PM | Ayala Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/06/2024
7:51 AM | Ayala Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/21/2023
8:00 AM | Ayala Pharmaceuticals (Subject)
Israel Biotech Fund I, L.P. (Filed by)
| Form SC 13D/A | |
11/21/2023
8:04 AM | Ayala Pharmaceuticals (Issuer)
I.B.F. Management Ltd. (Reporting)
Israel Biotech Fund GP Partners II, L.P. (Reporting)
Israel Biotech Fund GP Partners, L.P. (Reporting)
Israel Biotech Fund I, L.P. (Reporting)
Israel Biotech Fund II, L.P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
8:00 AM | Ayala Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/15/2023
3:04 PM | Ayala Pharmaceuticals (Filer)
| Form NT 10-Q | |
